Smart Search & Matching
Use AI-powered search to identify domestic and global partners aligned with your technology and business needs, then connect through inquiries and meetings.
Bridging Innovation and Opportunity
With digital transformation and AI, we connect innovators with the right investors and partners to maximize the chance that early-stage healthcare innovation becomes a successful business.
Korean life science startups
Global life science VCs
Global mid-sized pharmaceutical companies
Global network countries
2020.12
Founded
2021.08
Certified venture company
2021.12
Seed investment
2022.05
Pre-Series A investment
2022.08
Scoring service patent filed
2023.06
Chungbuk CCEI partner organization
2023.08
Selected for R&D TIPS and TIPS Global Marketing
2023.10
Global partnering service launched
2024.08
Biobook Platform MVP version launched
2025.08
Accelerator license acquired
2026.01
Registered provider for export/innovation voucher bio consulting
2026.08
Biobook officially launched
Use AI-powered search to identify domestic and global partners aligned with your technology and business needs, then connect through inquiries and meetings.
Explore Korean life science companies by indication, modality, technology area, and other industry classifications.
Search companies by regional and institutional clusters to identify relevant collaboration opportunities.
Access intelligence on the priority indications and modalities of global pharmaceutical companies and investors, including technology-sourcing, investment, and broader partnering strategies.
Define out-licensing positioning, objectives, and an execution strategy based on the asset's differentiation and market potential.
Shape the fundraising strategy, tailored IR materials, and key metrics needed for effective investor communication.
Identify global pharma and investor prospects for technology transfer, co-development, and fundraising.
Support the full transaction process, including due diligence, transaction term negotiations, and contract execution.
Support both basic content production and the development of strategic materials focused on concrete commercialization goals.
Produce a wide range of investor-relations content, from IR decks to video-based materials, that effectively communicates the strengths of each company and its technology.
Distribute IR content through the Biobook platform and diverse online and offline channels in Korea and abroad to expand partnering and investment opportunities.
Identify the needs of domestic and international pharmaceutical companies and investors, then connect them with promising companies to create new opportunities for innovation.